Bram Torenvliet

ORCID: 0009-0000-8508-6824
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peptidase Inhibition and Analysis
  • Chromatin Remodeling and Cancer
  • HIV/AIDS drug development and treatment
  • Cancer therapeutics and mechanisms
  • Malaria Research and Control
  • Drug-Induced Hepatotoxicity and Protection
  • Cancer-related gene regulation
  • Berberine and alkaloids research
  • Cancer Mechanisms and Therapy
  • Innovative Microfluidic and Catalytic Techniques Innovation

Erasmus MC
2024-2025

Erasmus University Rotterdam
2023-2024

Somatic mutations in ARID1A (AT-rich interactive domain-containing protein 1A) are present approximately 25% of bladder cancers (BC) and associated with poor prognosis. With a view to discover effective treatment options for ARID1A-deficient BC patients, we set out identify targetable effectors dysregulated consequent deficiency. Integrative analyses depletion normal organoids data mining publicly available datasets revealed upregulation DNA repair cell cycle-associated genes loss identified...

10.1101/2024.07.29.601702 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-08-02

Malaria, a major public health burden, is caused by Plasmodium spp parasites that first replicate in the human liver to establish infection before spreading erythrocytes. Liver-stage malaria research has remained challenging due lack of clinically relevant and scalable vitro model liver. Here, we demonstrate organoids derived from intrahepatic ductal cells differentiated into hepatocyte-like fate can support maturation falciparum. The P. falciparum exoerythrocytic forms observed expressed...

10.2139/ssrn.4380774 preprint EN 2023-01-01
Coming Soon ...